Thus, similarly to what occurs in melanoma [51], ILC2 targeted by anti-PD-1 antibodies might also become hyper-activated and recruit eosinophils in the skin, contributing to the onset of the eczematous AEs observed in ICI-treated melanoma patients. Here, PDCD1 is linked to melanoma.